NCT01679392View on ClinicalTrials.gov

A Study Investigating Properties of the Transversus Abdominis Plane Block

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Anesthesia, Local
Interventions
DRUG

Ropivacaine

Unilateral, single shot, ultrasound-guided, transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)

Trial Locations (1)

3400

Hillerød Hospital, Hillerød

All Listed Sponsors
lead

Hillerod Hospital, Denmark

OTHER

NCT01679392 - A Study Investigating Properties of the Transversus Abdominis Plane Block | Biotech Hunter | Biotech Hunter